William Hodder

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA.

Relievant Medsystems, Inc. develops treatment and technologies for chronic back pain. Its Intracept System solution is a minimally invasive procedure that uses radiofrequency energy delivered into the vertebral body of the spine to ablate the basivertebral nerve. Relievant Medsystems was founded by James C. Peacock, Jeffrey Charles Lotz, and Rex Peters in 2004 and is headquartered in Redwood City, CA.

PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.

ACT Venture Capital Ltd(ACT Venture Capital) is a independent venture capital firm founded by Niall Carroll and Owen Murphy in 1994.The firm is headquartered in Dublin,Ireland with an additional office in Belfast.

Spectra Biomedical, Inc. operates as a biotechnology company that created to use a focused bit of genomic bioinformatics, centered on various neurological conditions. The company was founded by Stephen J. Peroutka on January 1, 1993 and is headquartered in Philadelphia, PA.

Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA.

University of Iowa Hospitals and Clinics recognized as one of the best hospitals in the United States is Iowa's only comprehensive academic medical center. A 680-bed comprehensive academic medical center and regional referral center, UI Hospitals and Clinics is committed to providing patient-focused care available to every person, around the clock in an environment devoted to innovative care, excellent service, and exceptional outcomes. More than 760 staff physicians and dentists; 480 resident physicians and dentists; 180 fellow physicians; 1,565 nurses; and 4,640 other professional and support staff provide specialized care.

Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA.

Foundry Innovation & Research 1 Ltd. develops novel therapeutic devices. It has evolved into one of the leading clusters for medical devices globally. The company was headquartered in Dublin, Ireland.

Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland.

Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin.

Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA.

Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA.

Flow Pharma, Inc.operates as t-cell based vaccine delivery platform. The company was founded by Reid Rubsamen and is headquartered in Pleasant Hill, CA.

FIBRX Derm, Inc. develops anti-scarring therapeutic for patients with Dystrophic Epidermolysis Bullosa. The company was founded by Mark de Souza, James W. Fordyce and Erkki Ruoslahti and is headquartered in Berkeley, CA.

SeylanMED LLC operates as a private biopharmaceutical company that develops a targeted therapy for Seborrheic Keratosis. The company as founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA.

Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC.

Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA.

3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts.

SonALAsense, Inc. provides ALA Sonodynamic Therapy for the treatment of Glioblastoma Multiforme. The company was founded by Stuart Marcus and is headquartered in Berkeley, CA.

SeylanMED, Inc. engages in the development of topical akt inhibitor as a treatment for seborrheic keratosis. The company was founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA.

Mindrythm is a brain wellness company based in San Francisco, CA. Mindrythm develops medical technology to prevent neurological injury, with a focus on stroke prevention. The company's proprietary monitoring devices and communication platform aim to solve the triage problem in stroke, potentially saving more than 200,000 lives in 2022. The company was founded by John Keane and Paul Lovoi, with John Keane serving as the CEO since incorporation.

Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell.

NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation.

LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California.